The Stomach Cancer Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Stomach Cancer Market?
The market size for stomach cancer has seen significant growth recently. There was an increase from $3.27 billion in 2024 to $3.74 billion in 2025, representing a compound annual growth rate (CAGR) of 14.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Stomach Cancer Industry?
The Stomach Cancer Global Market Report 2025 predicts that by 2029, the market will grow to $6.28 billion, with a compound annual growth rate (CAGR) of 13.9%.
Download Your Free Sample of the 2025 Stomach Cancer Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Stomach Cancer Market?
The key drivers in the stomach cancer market are:
• Growing prevalence of Helicobacter pylori infections
• Poor sanitation contributing to higher infection rates
• Chronic inflammation and cellular damage from Helicobacter pylori infection
• Increased developments of precancerous changes and tumors in stomach lining due to infection.
Global Market Segmentation: Identifying Major Stomach Cancer Industry Segments
The stomach cancer market covered in this report is segmented –
1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types
2) By Therapy Type: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Ambulatory Surgery Centers, Hospitals And Specialty Clinics, Other End-Users
Pre-order the 2025 Stomach Cancer Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Stomach Cancer Market?
The key trends in the stomach cancer market are:
• There is a focus on the development of advanced solutions in the stomach cancer treatment market, such as claudin (CLDN18.2)-targeted cytolytic antibody therapy.
• The emergence of more precise first-line therapies is noted, especially for HER2-negative gastric and gastroesophageal junction (GEJ) adenocarcinoma.
• Improved survival outcomes are being promised due to innovative biologic therapies that combine selective binding to tumor cells and chemotherapy.
• Personalized oncology for advanced gastric cancer is gaining significance, with treatments designed to reduce off-target toxicity and increase specificity.
Who Are the Top Competitors & Leading Players in the Stomach Cancer Market?
Major players in the stomach cancer market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck And Co. Inc.
• Sanofi S.A.
• Bristol Myers Squibb Company
• AstraZeneca plc
• Novartis Ag
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited.
• Eli Lilly And Company
• Amgen Inc
• Mayo Clinic
• Daiichi Sankyo Company Limited.
• Illumina Inc.
• BeiGene Ltd.
• Celltrion Healthcare Co. Ltd.
• Biocon Limited.
• Guardant Health Inc.
• Zai Lab Limited.
• MacroGenics Inc.
Regional Dominance: Which Area Leads the Global Stomach Cancer Market?
North America was the largest region in the stomach cancer market in 2024
